Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients
The aim of this pilot clinical trial was to evaluate the safety of a new formulation of prolonged-release Pirfenidone (PR-PFD) in chronic kidney disease (CKD), specifically focal and segmental glomerular hyalinization (FSGH). Open-label, pilot, nonrandomized trial. Eighteen patients previously diagn...
Saved in:
Main Authors: | Simón A. Ojeda-Duran, Iván Lyra-Gonzalez, Alejandra Meza-Rios, Silvia Lucano-Landeros, Ana Sandoval-Rodriguez, Monica Vazquez-Del Mercado, Arturo Santos, Lucia Flores-Contreras, Juan Armendáriz-Borunda |
---|---|
Format: | Article |
Language: | English |
Published: |
Troika Publisher
2020-05-01
|
Series: | Journal of Renal and Hepatic Disorders |
Subjects: | |
Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/61 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab and Pirfenidone in the Treatment of Steroid‐Refractory Bleomycin Lung Injury
by: Aasir M. Suliman, et al.
Published: (2025-07-01) -
Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis?
by: Hikmet COBAN, et al.
Published: (2025-06-01) -
Pirfenidone reduces ovarian fibrosis and improves PCOS in letrozole-induced rat model
by: Ayşe Çakır Gündoğdu, et al.
Published: (2025-06-01) -
Cardiorenal relationships in individuals with various cardiomyopathies
by: I. V. Medvedenko, et al.
Published: (2025-05-01) -
Comparison of various prediction equations for glomerular filtration rate in Korean pediatric cancer patients: a retrospective study
by: Bo Ram Kim, et al.
Published: (2025-06-01)